Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

The SWIFT-1 and SWIFT-2 trials demonstrated that depemokimab, as an add-on therapy, significantly reduced exacerbation and hospitalization rates in patients with type 2 inflammation asthma.

GSK plc has announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, Labour and ...

Supply-side policy proponents argue that by targeting the economic variables that boost production, a trickle-down effect occurs as companies produce more and expand, they will employ more workers ...

Despite its extensive use and popularity, aspartame has become a source of controversy in recent years, with some research suggesting the sweetener has adverse health effects. It is not clear if ...

And it's all because of an unexpected side effect that has arguably saved her life. 'I had been in and out of hospitals for years,' recalls Hannah. 'At 15 I was diagnosed with anxiety, then ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...